Traditional vs. Posterior Nasal Radiofrequency Ablation for Chronic Rhinitis
NCT ID: NCT07323888
Last Updated: 2026-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2026-01-31
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Radiofrequency Ablation of Posterior Nasal Nerves on Inflammatory Cytokines, Peak Nasal Inspiratory Flow, and Nasal Blood Flow in Patients With Chronic Rhinitis
NCT05648565
The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis
NCT05276336
Randomized Trial Comparing Partial Resection of Inferior Turbinate(PRIT) and Radiofrequency Ablation(RFA) for Inferior Turbinate Reduction
NCT00358267
RhinAer Procedure for Treatment of Chronic Rhinitis Study
NCT04533438
A Randomized Study of Temperature-controlled and Bipolar Radiofrequency for Inferior Turbinate Reduction
NCT01054521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Posterior nasal radiofrequency ablation, which extends treatment to the middle and posterior portions of the inferior turbinate, has been proposed as an adjunctive technique to enhance symptom relief by targeting posterior nasal regions. Evidence comparing traditional anterior inferior turbinate radiofrequency ablation with expanded posterior nasal radiofrequency ablation remains limited.
In this prospective, single-center, randomized controlled trial, eligible patients with chronic rhinitis refractory to at least six months of medical therapy will be randomized in a 2:1 ratio to receive either expanded radiofrequency ablation including the middle and posterior portions of the inferior turbinate or traditional anterior inferior turbinate radiofrequency ablation alone. The primary outcome is the response rate based on improvement in reflective Total Nasal Symptom Score (rTNSS), defined as a ≥30% reduction from baseline at 3 months after the procedure. Secondary outcomes include changes in validated symptom and quality-of-life questionnaires and the incidence of procedure-related complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inferior Turbinate RF with Posterior Nasal RF Ablation
Traditional Radiofrequency Ablation of Inferior Turbinates With Posterior Nasal Radiofrequency Ablation
Traditional Radiofrequency Ablation of Inferior Turbinates With Posterior Nasal Radiofrequency Ablation
Intervention:
Radiofrequency Ablation (Olympus Celon Elite ESG-400)
* Local anesthesia with 2% lidocaine
* RF ablation at 15W
* Multiple punctures along anterior, middle, and posterior inferior turbinate (15-20 per side)
* Includes posterior nasal region (superior, medial, inferior aspects)
* No nasal packing required
Post-operative care (3 days):
1. Tranexamic acid 250mg 1cap BID x3 days
2. Amoxicillin 500mg 1 cap BID x3 days
3. Acetaminophen 500mg 1tab BID x3 days
4. Levocetirizine 5mg 1tab QD x3 days + PRN x4 days
Inferior Turbinate RF Ablation
Traditional Radiofrequency Ablation of Inferior Turbinates
Traditional Radiofrequency Ablation of Inferior Turbinates
Intervention:
Radiofrequency Ablation (anterior inferior turbinate only)
* Same anesthesia and device
* RF applied only to anterior inferior turbinate (≈2 punctures per side)
* No treatment to middle/posterior inferior turbinate Post-operative care: Same as experimental arm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Traditional Radiofrequency Ablation of Inferior Turbinates With Posterior Nasal Radiofrequency Ablation
Intervention:
Radiofrequency Ablation (Olympus Celon Elite ESG-400)
* Local anesthesia with 2% lidocaine
* RF ablation at 15W
* Multiple punctures along anterior, middle, and posterior inferior turbinate (15-20 per side)
* Includes posterior nasal region (superior, medial, inferior aspects)
* No nasal packing required
Post-operative care (3 days):
1. Tranexamic acid 250mg 1cap BID x3 days
2. Amoxicillin 500mg 1 cap BID x3 days
3. Acetaminophen 500mg 1tab BID x3 days
4. Levocetirizine 5mg 1tab QD x3 days + PRN x4 days
Traditional Radiofrequency Ablation of Inferior Turbinates
Intervention:
Radiofrequency Ablation (anterior inferior turbinate only)
* Same anesthesia and device
* RF applied only to anterior inferior turbinate (≈2 punctures per side)
* No treatment to middle/posterior inferior turbinate Post-operative care: Same as experimental arm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic rhinitis symptoms for at least 6 months that have not responded effectively to medication (should include at least Intranasal corticosteroid (ICS) combined with intermittent use of oral antihistamine and, as needed, combination nasal spray) or where medication has not provided sustained improvement
* Total rTNSS ≥ 4 with Moderate to severe rhinorrhea symptoms (24-hour reflective Total Nasal Symptom Score \[rTNSS\] rhinorrhea score of 1-3) and mild to severe nasal congestion symptoms (rTNSS nasal congestion score of 1-3)
* All enrolled patients routinely undergo endonasal endoscopic examination, or have had a sinus CT within the past month confirming no significant rhinosinusitis."
Exclusion Criteria
* Nasal anatomical changes due to previous sinus or nasal surgery or injury
* Ongoing nasal or sinus infection
* History of severe dry eye, chronic epistaxis, rhinitis medicamentosa, or head and neck radiotherapy
* Self-reported history of bleeding tendency
* Current use of anticoagulants with inability to discontinue
* Previous chronic rhinitis surgery
* History of poor wound healing after head, neck, or throat surgery
* Pregnancy/lactation
* Neuromuscular disease preventing supine positioning
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chien Yu Huang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chien Yu Huang
Attending Physician, Department of Otolaryngology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chiayi Hospital, Ministry of Health and Welfare (MOHW)
Chiayi City, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Stolovitzky JP, Ow RA, Silvers SL, Bikhazi NB, Johnson CD, Takashima M. Effect of Radiofrequency Neurolysis on the Symptoms of Chronic Rhinitis: A Randomized Controlled Trial. OTO Open. 2021 Sep 10;5(3):2473974X211041124. doi: 10.1177/2473974X211041124. eCollection 2021 Jul-Sep.
Ehmer D, McDuffie CM, Scurry WC Jr, McIntyre JB, Mehendale NH, Willis JH, Shealy RB, Watkins JP, Kakarlapudi VV. Temperature-Controlled Radiofrequency Neurolysis for the Treatment of Rhinitis. Am J Rhinol Allergy. 2022 Jan;36(1):149-156. doi: 10.1177/19458924211033400. Epub 2021 Aug 12.
Lee JT, Abbas GM, Charous DD, Cuevas PDMM, Goktas PDMO, Loftus PA, Nachlas NE, Toskala EM, Watkins JP, Brehmer PDMD. Clinical and Quality of Life Outcomes Following Temperature-Controlled Radiofrequency Neurolysis of the Posterior Nasal Nerve (RhinAer) for Treatment of Chronic Rhinitis. Am J Rhinol Allergy. 2022 Nov;36(6):747-754. doi: 10.1177/19458924221109987. Epub 2022 Jul 11.
Takashima M, Stolovitzky JP, Ow RA, Silvers SL, Bikhazi NB, Johnson CD. Temperature-controlled radiofrequency neurolysis for treatment of chronic rhinitis: 12-month outcomes after treatment in a randomized controlled trial. Int Forum Allergy Rhinol. 2023 Feb;13(2):107-115. doi: 10.1002/alr.23047. Epub 2022 Jul 5.
Related Links
Access external resources that provide additional context or updates about the study.
Position Statement: PNN Ablation for the Treatment of Chronic Rhinitis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25-013
Identifier Type: OTHER
Identifier Source: secondary_id
IRB 25-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.